• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.住院时间累积长度对重症外科患者分离的念珠菌菌株的抗真菌耐药性的影响。
Mycopathologia. 2011 Feb;171(2):85-91. doi: 10.1007/s11046-010-9369-3. Epub 2010 Oct 8.
2
Risk factors for isolation of fluconazole and echinocandin non-susceptible species in critically ill patients.危重症患者中氟康唑和棘白菌素非敏感性物种分离的危险因素。
J Med Microbiol. 2021 Aug;70(8). doi: 10.1099/jmm.0.001401.
3
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].念珠菌属对三唑类药物的抗真菌药敏谱:应用美国临床和实验室标准协会(CLSI)新的种特异性临床折点和流行病学截断值来表征抗真菌药物耐药性
Mikrobiyol Bul. 2016 Jan;50(1):122-32. doi: 10.5578/mb.10682.
4
Risk factors for fluconazole-resistant candidemia.氟康唑耐药念珠菌血症的危险因素。
Antimicrob Agents Chemother. 2010 Aug;54(8):3149-54. doi: 10.1128/AAC.00479-10. Epub 2010 May 24.
5
Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.一家三级护理医院中非白色念珠菌属的出现及抗真菌耐药性
Jpn J Infect Dis. 2005 Dec;58(6):344-8.
6
Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.HIV感染患者念珠菌分离株对抗真菌药物的敏感性及体内外相关性的横断面研究。
AIDS. 1994 Jul;8(7):945-50. doi: 10.1097/00002030-199407000-00011.
7
Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.来自尼日利亚拉各斯抗逆转录病毒诊所就诊的HIV感染患者的耐氟康唑机会性口咽念珠菌和非念珠菌酵母样分离株。
Afr Health Sci. 2008 Sep;8(3):142-8.
8
Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.引起医院获得性尿念珠菌病的念珠菌属种的分布及抗真菌药敏性。
Med Mycol. 2012 Jul;50(5):529-32. doi: 10.3109/13693786.2011.618996. Epub 2011 Oct 11.
9
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.念珠菌属对四种抗真菌药物的体外药敏谱。委内瑞拉菌株的耐药性监测研究。
Med Mycol. 2009 Mar;47(2):137-43. doi: 10.1080/13693780802144339. Epub 2008 Jun 27.
10
In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).在瓦加杜古(布基纳法索)对 8 种抗真菌药物的白色念珠菌临床分离株的体外敏感性。
J Mycol Med. 2017 Dec;27(4):469-475. doi: 10.1016/j.mycmed.2017.07.001. Epub 2017 Jul 25.

引用本文的文献

1
Investigating role of positively selected genes and mutation sites of ERG11 in drug resistance of Candida albicans.研究 ERG11 基因中阳性选择基因和突变位点在白念珠菌耐药性中的作用。
Arch Microbiol. 2024 Oct 18;206(11):437. doi: 10.1007/s00203-024-04159-1.
2
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Species.与致病物种中抗真菌耐药性相关的分子机制。
Cells. 2023 Nov 19;12(22):2655. doi: 10.3390/cells12222655.
3
Case report: Candidiasis of gastrojejunostomosis after pancreaticoduodenectomy: Preliminary experience from two cases.病例报告:胰十二指肠切除术后胃空肠吻合口念珠菌病:两例初步经验
Front Oncol. 2022 Aug 24;12:888927. doi: 10.3389/fonc.2022.888927. eCollection 2022.
4
Gastric Candidiasis Leading to Perforation: An Unusual Presentation.导致穿孔的胃念珠菌病:一种不寻常的表现。
Cureus. 2021 Sep 10;13(9):e17878. doi: 10.7759/cureus.17878. eCollection 2021 Sep.
5
Perforated and bleeding peptic ulcer: WSES guidelines.穿孔和出血性消化性溃疡:WSES 指南。
World J Emerg Surg. 2020 Jan 7;15:3. doi: 10.1186/s13017-019-0283-9. eCollection 2020.
6
Ethnopharmacological Potentials of Warburgia ugandensis on Antimicrobial Activities.《乌干达崖豆藤的民族药理学潜力对抗菌活性的影响》
Chin J Integr Med. 2021 Aug;27(8):633-640. doi: 10.1007/s11655-019-3042-6. Epub 2019 Dec 17.
7
An Italian consensus for invasive candidiasis management (ITALIC).意大利侵袭性念珠菌病管理共识(ITALIC)。
Infection. 2014 Apr;42(2):263-79. doi: 10.1007/s15010-013-0558-0. Epub 2013 Nov 25.
8
Candida peritonitis: an update on the latest research and treatments.念珠菌性腹膜炎:最新研究与治疗进展
World J Surg. 2011 Dec;35(12):2650-9. doi: 10.1007/s00268-011-1305-2.

本文引用的文献

1
Candida infection and colonization among trauma patients.创伤患者中的念珠菌感染和定植。
Virulence. 2010 Sep-Oct;1(5):367-75. doi: 10.4161/viru.1.5.12796.
2
Candida infection and colonization among non-trauma emergency surgery patients.非创伤性急诊手术患者中的念珠菌感染和定植。
Virulence. 2010 Sep-Oct;1(5):359-66. doi: 10.4161/viru.1.5.12795.
3
[Evaluation of susceptibility to antifungal agents of fungal strains isolated from pregnant women with diabetes and healthy pregnant women].[对从患有糖尿病的孕妇和健康孕妇中分离出的真菌菌株对抗真菌剂的敏感性评估]
Ginekol Pol. 2009 Apr;80(4):274-9.
4
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.2019例念珠菌血症患者的流行病学及转归:来自前瞻性抗真菌治疗联盟登记处的数据
Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039.
5
Dynamics of in vitro acquisition of resistance by Candida parapsilosis to different azoles.近平滑念珠菌对不同唑类药物体外耐药性获得的动态变化
FEMS Yeast Res. 2009 Jun;9(4):626-33. doi: 10.1111/j.1567-1364.2009.00508.x. Epub 2009 Apr 6.
6
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections.氟康唑耐药光滑念珠菌血流感染的危险因素。
Arch Intern Med. 2009 Feb 23;169(4):379-83. doi: 10.1001/archinte.169.4.379.
7
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.念珠菌病管理临床实践指南:美国传染病学会2009年更新版
Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.
8
Treatment-related risk factors for hospital mortality in Candida bloodstream infections.念珠菌血流感染中与治疗相关的医院死亡率风险因素。
Crit Care Med. 2008 Nov;36(11):2967-72. doi: 10.1097/CCM.0b013e31818b3477.
9
Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.非中性粒细胞减少的重症患者念珠菌血症:非白色念珠菌属的危险因素
Crit Care Med. 2008 Jul;36(7):2034-9. doi: 10.1097/CCM.0b013e3181760f42.
10
Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.重症监护病房中由非白色念珠菌属念珠菌与白色念珠菌引起的念珠菌血症相关因素。
Clin Infect Dis. 2008 Apr 15;46(8):1206-13. doi: 10.1086/529435.

住院时间累积长度对重症外科患者分离的念珠菌菌株的抗真菌耐药性的影响。

The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.

机构信息

Department of Medicine, Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Gray-Jackson 504, 55 Fruit St, Boston, MA 02114, USA.

出版信息

Mycopathologia. 2011 Feb;171(2):85-91. doi: 10.1007/s11046-010-9369-3. Epub 2010 Oct 8.

DOI:10.1007/s11046-010-9369-3
PMID:20927595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4093797/
Abstract

Fluconazole is the first line of therapy for the management of candidiasis. However, fluconazole-resistant strains pose an emerging challenge in everyday clinical practice. In this study, we sought to determine whether cumulative length of hospital stay (CLOS) is a predictive factor for the acquisition of non-susceptible Candida strains to fluconazole. Thirty-three critically ill emergency surgery patients with 56 Candida isolates were enrolled in this prospective study. We divided our isolates according to their minimum inhibitory concentration (MIC) to fluconazole using 8 mcg/ml as a cutoff. We then compared the two groups with respect to basic demographics, antifungal agents prescribed, number of wide-spectrum antibiotics, duration of central venous catheter placement, elapsed time to positive culture, duration of prior hospital stay, and length of hospital stay. Non-susceptible fluconazole samples belonged to patients with a significantly longer prior hospital stay and a longer CLOS (P = 0.02 and 0.01, respectively). The difference between the 2 groups regarding non-albicans strains was statistically significant (P < 0.001). By fitting a non-parametric receiver-operating characteristics (ROC) curve into our analysis, a CLOS ≥ 29 days predicted the occurrence of non-susceptible strains with 90% sensitivity and 79.6% specificity (correct classification 81.5%). A CLOS ≥ 29 days is a strong predictor for the isolation of non-susceptible Candida isolates to fluconazole among critically ill emergency surgery patients. Clinicians should consider the duration of previous hospital stay when deciding on empiric antifungal therapy.

摘要

氟康唑是治疗念珠菌病的一线治疗药物。然而,氟康唑耐药株在日常临床实践中构成了一个新出现的挑战。在这项研究中,我们试图确定住院时间(CLOS)是否是获得对氟康唑不敏感的念珠菌株的预测因素。这项前瞻性研究纳入了 33 名患有 56 株念珠菌分离株的重症急救手术患者。我们根据最低抑菌浓度(MIC)将我们的分离株分为氟康唑 8μg/ml 作为临界值。然后,我们比较了两组患者的基本人口统计学数据、抗真菌药物的使用、广谱抗生素的数量、中心静脉导管放置时间、阳性培养的时间、先前住院时间和住院时间。非敏感氟康唑样本来自先前住院时间和 CLOS 较长的患者(P=0.02 和 0.01)。两组之间关于非白色念珠菌菌株的差异具有统计学意义(P<0.001)。通过将非参数接收器操作特性(ROC)曲线拟合到我们的分析中,CLOS≥29 天可预测非敏感菌株的发生,敏感性为 90%,特异性为 79.6%(正确分类 81.5%)。CLOS≥29 天是重症急救手术患者中分离出对氟康唑不敏感的念珠菌株的有力预测因素。临床医生在决定经验性抗真菌治疗时应考虑先前住院时间的长短。